IMPROVED THERAPEUTIC INDEX WITH SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE PLUS HIGH-DOSE METHOTREXATE PLUS HIGH-DOSE 5-FLUOROURACIL AND APPROPRIATE RESCUE

被引：0
|
作者：
MARTIN, DS
STOLFI, RL
SAWYER, RC
SPIEGELMAN, S
YOUNG, CW
机构：
[1] COLUMBIA UNIV,INST CANC RES,NEW YORK,NY 10032
[2] MEM SLOAN KETTERING CANC CTR,DEPT DEV CHEMOTHERAPY,NEW YORK,NY 10021
[3] CATHOLIC MED CTR,DEPT SURG,NEW YORK,NY 11421
来源：
CANCER RESEARCH | 1983年 / 43卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4653 / 4661
页数：9
相关论文
共 50 条
  • [1] A PHASE-II TRIAL OF BIOCHEMICAL MODULATION USING N-PHOSPHONACETYL-L-ASPARTATE, HIGH-DOSE METHOTREXATE, HIGH-DOSE 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADENOCARCINOMA OF UNKNOWN PRIMARY SITE
    KELSEN, D
    MARTIN, DS
    COLOFIORE, J
    SAWYER, R
    COIT, D
    CANCER, 1992, 70 (07) : 1988 - 1992
  • [2] URIDINE ALLOWS DOSE ESCALATION OF 5-FLUOROURACIL WHEN GIVEN WITH N-PHOSPHONACETYL-L-ASPARTATE, METHOTREXATE, AND LEUCOVORIN
    SEITER, K
    KEMENY, N
    MARTIN, D
    SCHNEIDER, A
    WILLIAMS, L
    COLOFIORE, J
    SAWYER, R
    CANCER, 1993, 71 (05) : 1875 - 1881
  • [3] HIGH-DOSE 5-FLUOROURACIL WITH DELAYED URIDINE RESCUE IN MICE
    MARTIN, DS
    STOLFI, RL
    SAWYER, RC
    SPIEGELMAN, S
    YOUNG, CW
    CANCER RESEARCH, 1982, 42 (10) : 3964 - 3970
  • [4] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (HIGH-DOSE), AND DOXORUBICIN FOR ADVANCED GASTRIC-CANCER
    MURO, H
    ACUNA, LR
    CASTAGNARI, A
    BLAJMAN, C
    SCHMILOVICH, A
    HIDALGO, A
    FIORI, H
    BADER, M
    MARANTZ, A
    CANCER TREATMENT REPORTS, 1986, 70 (11): : 1333 - 1334
  • [5] SEQUENTIAL HIGH-DOSE METHOTREXATE AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    HEIM, ME
    FLECHTNER, H
    EDLER, L
    QUEISSER, W
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (05) : 197 - 200
  • [6] MODULATION OF HIGH-DOSE METHOTREXATE TOXICITY BY A NONTOXIC LEVEL OF 5-FLUOROURACIL
    ROBBINS, TJ
    BOWEN, D
    BUI, QQ
    TRAN, MT
    TOXICOLOGY, 1986, 41 (01) : 61 - 73
  • [7] SEQUENTIAL HIGH-DOSE METHOTREXATE, 5-FLUOROURACIL, AND DOXORUBICIN FOR TREATMENT OF ADVANCED PANCREATIC-CANCER
    SCHEITHAUER, W
    FUNOVICS, J
    MUELLER, C
    LUDWIG, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (02) : 132 - 133
  • [8] A phase I trial of a modified, dose intensive FAMTX regimen (High dose 5-fluorouracil plus doxorubicin plus high dose methotrexate plus leucovorin) with oral uridine rescue
    Schwartz, GK
    Christman, K
    Saltz, L
    Casper, E
    Quan, V
    Bertino, J
    Martin, DS
    Colofiore, J
    CANCER, 1996, 78 (09) : 1988 - 1995
  • [9] PHASE-I STUDY OF HIGH-DOSE 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN WITH LOW-DOSE PHOSPHONACETYL-L-ASPARTIC ACID IN PATIENTS WITH ADVANCED MALIGNANCIES
    ARDALAN, B
    STRIDHAR, K
    REDDY, R
    BENEDETTO, P
    RICHMAN, S
    WALDMAN, S
    MORRELL, L
    FEUN, L
    SAVARAJ, N
    LIVINGSTONE, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (03): : 511 - 514
  • [10] POSSIBLE MECHANISMS FOR THE IMPROVED THERAPEUTIC ACTIVITY OF HIGH-DOSE METHOTREXATE (HDMTX) WITH RESCUE
    SAMUELS, LL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 273 - 273
12345